CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for PRA Health Sciences Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

PRA Health Sciences Inc
4130 Parklake Ave Ste 400
Phone: (919) 786-8200p:919 786-8200 Raleigh, NC  27612-4462  United States Ticker: 8PH8PH
This company was Merged or Acquired on 7/1/2021.
This company ceased filing statements with the SEC on 7/13/2021.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
PRA Health Sciences, Inc. is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. Its services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. It provides its clients with clinical development service offerings, which includes both traditional, project-based Phase I through Phase IV services, as well as embedded and functional outsourcing services. As of December 31, 2016, its clinical development platform included approximately 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East. The Company's service offerings include product registration, strategic solutions and early development services.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-YesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202112/31/2020YesYes---

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer ColinShannon 60 1/1/2014 1/1/2010
Chief Financial Officer, Executive Vice President Michael J.Bonello 50 5/1/2018
Executive Vice President, Chief Administrative Officer, General Counsel Christopher L.Gaenzle 53 4/1/2019 4/1/2019
5 additional Officers and Directors records available in full report.

Business Names
Business Name
3065613 Nova Scotia Company
8PH
Care Innovations (UK) Limited
112 additional Business Names available in full report.

General Information
Number of Employees: 18,100 (As of 12/31/2020)
Outstanding Shares: 64,795,400 (As of 4/26/2021)
Shareholders: 265
Stock Exchange: NASD
Federal Tax Id: 463640387
Fax Number: (919) 786-8201


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, April 8, 2024